May 15 |
Parkinson's-focused Serina Therapeutics, Enable Injections enter partnership
|
May 15 |
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
|
May 14 |
AgeX Therapeutics GAAP EPS of -$3.38, revenue of $0.05M
|
May 14 |
Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
|
May 3 |
Serina Therapeutics files to sell 1.5M shares of common stock
|
Apr 17 |
Serina Therapeutics appoints Simba Gill as executive chairman
|
Apr 17 |
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
|
Mar 25 |
AgeX Therapeutics GAAP EPS of -$13.73
|
Mar 22 |
AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
|